Cardiovascular risk in persons at risk of developing rheumatoid arthritis

Background Rheumatoid arthritis (RA) is associated with an increased cardiovascular disease (CVD) risk which may start even before diagnosis. To explore this CVD risk prior to RA, we determined multiple risk factors and two 10-year clinical risk scores in a cohort of individuals at-risk of RA. We al...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 15; no. 8; p. e0237072
Main Authors van Boheemen, Laurette, van Beers-Tas, Marian H., Kroese, Johanna M., van de Stadt, Lotte A., van Schaardenburg, Dirkjan, Nurmohamed, Michael T.
Format Journal Article
LanguageEnglish
Published San Francisco Public Library of Science 03.08.2020
Public Library of Science (PLoS)
Subjects
Online AccessGet full text
ISSN1932-6203
1932-6203
DOI10.1371/journal.pone.0237072

Cover

Abstract Background Rheumatoid arthritis (RA) is associated with an increased cardiovascular disease (CVD) risk which may start even before diagnosis. To explore this CVD risk prior to RA, we determined multiple risk factors and two 10-year clinical risk scores in a cohort of individuals at-risk of RA. We also analyzed associations with arthritis development and autoantibody status and compared a subset of at-risk individuals to an age and sex matched seronegative control group. Methods In a cohort of 555 consecutive arthralgia patients positive for rheumatoid factor (RF) and / or anti-citrullinated protein antibody (ACPA) we retrospectively identified patients with preclinical arthritis (i.e. those who developed arthritis), and non-arthritis patients (those without arthritis development during maximum 5 years follow up). Demographics, CVD risk factors and the 10-year cardiovascular risk according to the SCORE and QRISK3 system were determined at baseline. Results Preclinical arthritis patients (n = 188) had a higher heart rate (68 vs 63 bpm, p = 0.048) and lower cholesterol (5.2 mmol/l vs 5.5, p = 0.006), HDL (1.0 mmol/l vs 1.1, p0.003) and ApoB (0.85 g/l vs 0.91, p = 0.011) compared to non-arthritis patients (n = 367). Lipid levels were associated with ACPA status in both the preclinical arthritis and non-arthritis group. Ten-year CVD risk scores did not differ between preclinical arthritis and non-arthritis patients, in total, 7% (SCORE) and 8% (QRISK3) of seropositive arthralgia patients were classified as high risk. Seropositive at-risk patients (n = 71) had higher total cholesterol (5.4 vs 4.9, p<0.001), TC/HDL ratio (4.0 vs 3.0, p<0.001), triglycerides (1.4 vs 1.0, p = 0.001), ApoB (1.0 vs 0.9, p = 0.019) and 10-year risk scores (median SCORE 1.0 vs 0.0, p = 0.030 and median QRISK3 4.4 vs 3.1, p<0.001) compared to seronegative controls. Conclusion Our results suggest that lipid changes commence prior to RA diagnosis and that ACPAs might play a role.
AbstractList Background Rheumatoid arthritis (RA) is associated with an increased cardiovascular disease (CVD) risk which may start even before diagnosis. To explore this CVD risk prior to RA, we determined multiple risk factors and two 10-year clinical risk scores in a cohort of individuals at-risk of RA. We also analyzed associations with arthritis development and autoantibody status and compared a subset of at-risk individuals to an age and sex matched seronegative control group. Methods In a cohort of 555 consecutive arthralgia patients positive for rheumatoid factor (RF) and / or anti-citrullinated protein antibody (ACPA) we retrospectively identified patients with preclinical arthritis (i.e. those who developed arthritis), and non-arthritis patients (those without arthritis development during maximum 5 years follow up). Demographics, CVD risk factors and the 10-year cardiovascular risk according to the SCORE and QRISK3 system were determined at baseline. Results Preclinical arthritis patients (n = 188) had a higher heart rate (68 vs 63 bpm, p = 0.048) and lower cholesterol (5.2 mmol/l vs 5.5, p = 0.006), HDL (1.0 mmol/l vs 1.1, p0.003) and ApoB (0.85 g/l vs 0.91, p = 0.011) compared to non-arthritis patients (n = 367). Lipid levels were associated with ACPA status in both the preclinical arthritis and non-arthritis group. Ten-year CVD risk scores did not differ between preclinical arthritis and non-arthritis patients, in total, 7% (SCORE) and 8% (QRISK3) of seropositive arthralgia patients were classified as high risk. Seropositive at-risk patients (n = 71) had higher total cholesterol (5.4 vs 4.9, p<0.001), TC/HDL ratio (4.0 vs 3.0, p<0.001), triglycerides (1.4 vs 1.0, p = 0.001), ApoB (1.0 vs 0.9, p = 0.019) and 10-year risk scores (median SCORE 1.0 vs 0.0, p = 0.030 and median QRISK3 4.4 vs 3.1, p<0.001) compared to seronegative controls. Conclusion Our results suggest that lipid changes commence prior to RA diagnosis and that ACPAs might play a role.
Rheumatoid arthritis (RA) is associated with an increased cardiovascular disease (CVD) risk which may start even before diagnosis. To explore this CVD risk prior to RA, we determined multiple risk factors and two 10-year clinical risk scores in a cohort of individuals at-risk of RA. We also analyzed associations with arthritis development and autoantibody status and compared a subset of at-risk individuals to an age and sex matched seronegative control group. In a cohort of 555 consecutive arthralgia patients positive for rheumatoid factor (RF) and / or anti-citrullinated protein antibody (ACPA) we retrospectively identified patients with preclinical arthritis (i.e. those who developed arthritis), and non-arthritis patients (those without arthritis development during maximum 5 years follow up). Demographics, CVD risk factors and the 10-year cardiovascular risk according to the SCORE and QRISK3 system were determined at baseline. Preclinical arthritis patients (n = 188) had a higher heart rate (68 vs 63 bpm, p = 0.048) and lower cholesterol (5.2 mmol/l vs 5.5, p = 0.006), HDL (1.0 mmol/l vs 1.1, p0.003) and ApoB (0.85 g/l vs 0.91, p = 0.011) compared to non-arthritis patients (n = 367). Lipid levels were associated with ACPA status in both the preclinical arthritis and non-arthritis group. Ten-year CVD risk scores did not differ between preclinical arthritis and non-arthritis patients, in total, 7% (SCORE) and 8% (QRISK3) of seropositive arthralgia patients were classified as high risk. Seropositive at-risk patients (n = 71) had higher total cholesterol (5.4 vs 4.9, p<0.001), TC/HDL ratio (4.0 vs 3.0, p<0.001), triglycerides (1.4 vs 1.0, p = 0.001), ApoB (1.0 vs 0.9, p = 0.019) and 10-year risk scores (median SCORE 1.0 vs 0.0, p = 0.030 and median QRISK3 4.4 vs 3.1, p<0.001) compared to seronegative controls. Our results suggest that lipid changes commence prior to RA diagnosis and that ACPAs might play a role.
Background Rheumatoid arthritis (RA) is associated with an increased cardiovascular disease (CVD) risk which may start even before diagnosis. To explore this CVD risk prior to RA, we determined multiple risk factors and two 10-year clinical risk scores in a cohort of individuals at-risk of RA. We also analyzed associations with arthritis development and autoantibody status and compared a subset of at-risk individuals to an age and sex matched seronegative control group. Methods In a cohort of 555 consecutive arthralgia patients positive for rheumatoid factor (RF) and / or anti-citrullinated protein antibody (ACPA) we retrospectively identified patients with preclinical arthritis (i.e. those who developed arthritis), and non-arthritis patients (those without arthritis development during maximum 5 years follow up). Demographics, CVD risk factors and the 10-year cardiovascular risk according to the SCORE and QRISK3 system were determined at baseline. Results Preclinical arthritis patients (n = 188) had a higher heart rate (68 vs 63 bpm, p = 0.048) and lower cholesterol (5.2 mmol/l vs 5.5, p = 0.006), HDL (1.0 mmol/l vs 1.1, p0.003) and ApoB (0.85 g/l vs 0.91, p = 0.011) compared to non-arthritis patients (n = 367). Lipid levels were associated with ACPA status in both the preclinical arthritis and non-arthritis group. Ten-year CVD risk scores did not differ between preclinical arthritis and non-arthritis patients, in total, 7% (SCORE) and 8% (QRISK3) of seropositive arthralgia patients were classified as high risk. Seropositive at-risk patients (n = 71) had higher total cholesterol (5.4 vs 4.9, p<0.001), TC/HDL ratio (4.0 vs 3.0, p<0.001), triglycerides (1.4 vs 1.0, p = 0.001), ApoB (1.0 vs 0.9, p = 0.019) and 10-year risk scores (median SCORE 1.0 vs 0.0, p = 0.030 and median QRISK3 4.4 vs 3.1, p<0.001) compared to seronegative controls. Conclusion Our results suggest that lipid changes commence prior to RA diagnosis and that ACPAs might play a role.
BackgroundRheumatoid arthritis (RA) is associated with an increased cardiovascular disease (CVD) risk which may start even before diagnosis. To explore this CVD risk prior to RA, we determined multiple risk factors and two 10-year clinical risk scores in a cohort of individuals at-risk of RA. We also analyzed associations with arthritis development and autoantibody status and compared a subset of at-risk individuals to an age and sex matched seronegative control group.MethodsIn a cohort of 555 consecutive arthralgia patients positive for rheumatoid factor (RF) and / or anti-citrullinated protein antibody (ACPA) we retrospectively identified patients with preclinical arthritis (i.e. those who developed arthritis), and non-arthritis patients (those without arthritis development during maximum 5 years follow up). Demographics, CVD risk factors and the 10-year cardiovascular risk according to the SCORE and QRISK3 system were determined at baseline.ResultsPreclinical arthritis patients (n = 188) had a higher heart rate (68 vs 63 bpm, p = 0.048) and lower cholesterol (5.2 mmol/l vs 5.5, p = 0.006), HDL (1.0 mmol/l vs 1.1, p0.003) and ApoB (0.85 g/l vs 0.91, p = 0.011) compared to non-arthritis patients (n = 367). Lipid levels were associated with ACPA status in both the preclinical arthritis and non-arthritis group. Ten-year CVD risk scores did not differ between preclinical arthritis and non-arthritis patients, in total, 7% (SCORE) and 8% (QRISK3) of seropositive arthralgia patients were classified as high risk. Seropositive at-risk patients (n = 71) had higher total cholesterol (5.4 vs 4.9, p<0.001), TC/HDL ratio (4.0 vs 3.0, p<0.001), triglycerides (1.4 vs 1.0, p = 0.001), ApoB (1.0 vs 0.9, p = 0.019) and 10-year risk scores (median SCORE 1.0 vs 0.0, p = 0.030 and median QRISK3 4.4 vs 3.1, p<0.001) compared to seronegative controls.ConclusionOur results suggest that lipid changes commence prior to RA diagnosis and that ACPAs might play a role.
Rheumatoid arthritis (RA) is associated with an increased cardiovascular disease (CVD) risk which may start even before diagnosis. To explore this CVD risk prior to RA, we determined multiple risk factors and two 10-year clinical risk scores in a cohort of individuals at-risk of RA. We also analyzed associations with arthritis development and autoantibody status and compared a subset of at-risk individuals to an age and sex matched seronegative control group.BACKGROUNDRheumatoid arthritis (RA) is associated with an increased cardiovascular disease (CVD) risk which may start even before diagnosis. To explore this CVD risk prior to RA, we determined multiple risk factors and two 10-year clinical risk scores in a cohort of individuals at-risk of RA. We also analyzed associations with arthritis development and autoantibody status and compared a subset of at-risk individuals to an age and sex matched seronegative control group.In a cohort of 555 consecutive arthralgia patients positive for rheumatoid factor (RF) and / or anti-citrullinated protein antibody (ACPA) we retrospectively identified patients with preclinical arthritis (i.e. those who developed arthritis), and non-arthritis patients (those without arthritis development during maximum 5 years follow up). Demographics, CVD risk factors and the 10-year cardiovascular risk according to the SCORE and QRISK3 system were determined at baseline.METHODSIn a cohort of 555 consecutive arthralgia patients positive for rheumatoid factor (RF) and / or anti-citrullinated protein antibody (ACPA) we retrospectively identified patients with preclinical arthritis (i.e. those who developed arthritis), and non-arthritis patients (those without arthritis development during maximum 5 years follow up). Demographics, CVD risk factors and the 10-year cardiovascular risk according to the SCORE and QRISK3 system were determined at baseline.Preclinical arthritis patients (n = 188) had a higher heart rate (68 vs 63 bpm, p = 0.048) and lower cholesterol (5.2 mmol/l vs 5.5, p = 0.006), HDL (1.0 mmol/l vs 1.1, p0.003) and ApoB (0.85 g/l vs 0.91, p = 0.011) compared to non-arthritis patients (n = 367). Lipid levels were associated with ACPA status in both the preclinical arthritis and non-arthritis group. Ten-year CVD risk scores did not differ between preclinical arthritis and non-arthritis patients, in total, 7% (SCORE) and 8% (QRISK3) of seropositive arthralgia patients were classified as high risk. Seropositive at-risk patients (n = 71) had higher total cholesterol (5.4 vs 4.9, p<0.001), TC/HDL ratio (4.0 vs 3.0, p<0.001), triglycerides (1.4 vs 1.0, p = 0.001), ApoB (1.0 vs 0.9, p = 0.019) and 10-year risk scores (median SCORE 1.0 vs 0.0, p = 0.030 and median QRISK3 4.4 vs 3.1, p<0.001) compared to seronegative controls.RESULTSPreclinical arthritis patients (n = 188) had a higher heart rate (68 vs 63 bpm, p = 0.048) and lower cholesterol (5.2 mmol/l vs 5.5, p = 0.006), HDL (1.0 mmol/l vs 1.1, p0.003) and ApoB (0.85 g/l vs 0.91, p = 0.011) compared to non-arthritis patients (n = 367). Lipid levels were associated with ACPA status in both the preclinical arthritis and non-arthritis group. Ten-year CVD risk scores did not differ between preclinical arthritis and non-arthritis patients, in total, 7% (SCORE) and 8% (QRISK3) of seropositive arthralgia patients were classified as high risk. Seropositive at-risk patients (n = 71) had higher total cholesterol (5.4 vs 4.9, p<0.001), TC/HDL ratio (4.0 vs 3.0, p<0.001), triglycerides (1.4 vs 1.0, p = 0.001), ApoB (1.0 vs 0.9, p = 0.019) and 10-year risk scores (median SCORE 1.0 vs 0.0, p = 0.030 and median QRISK3 4.4 vs 3.1, p<0.001) compared to seronegative controls.Our results suggest that lipid changes commence prior to RA diagnosis and that ACPAs might play a role.CONCLUSIONOur results suggest that lipid changes commence prior to RA diagnosis and that ACPAs might play a role.
Audience Academic
Author Kroese, Johanna M.
van Schaardenburg, Dirkjan
van de Stadt, Lotte A.
van Boheemen, Laurette
van Beers-Tas, Marian H.
Nurmohamed, Michael T.
AuthorAffiliation 2 Departments of Orofacial Pain and Dysfunction, Periodontology, and Preventive Dentistry, Academic Center for Dentistry Amsterdam, University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
University of Milano, ITALY
4 Department of Rheumatology, Amsterdam University Medical Centers, VUmc, Amsterdam, The Netherlands
1 Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam, The Netherlands
3 Department of Rheumatology, Amsterdam University Medical Centers, AMC, Amsterdam, The Netherlands
AuthorAffiliation_xml – name: 1 Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Reade, Amsterdam, The Netherlands
– name: University of Milano, ITALY
– name: 3 Department of Rheumatology, Amsterdam University Medical Centers, AMC, Amsterdam, The Netherlands
– name: 2 Departments of Orofacial Pain and Dysfunction, Periodontology, and Preventive Dentistry, Academic Center for Dentistry Amsterdam, University of Amsterdam and Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
– name: 4 Department of Rheumatology, Amsterdam University Medical Centers, VUmc, Amsterdam, The Netherlands
Author_xml – sequence: 1
  givenname: Laurette
  orcidid: 0000-0003-3168-548X
  surname: van Boheemen
  fullname: van Boheemen, Laurette
– sequence: 2
  givenname: Marian H.
  surname: van Beers-Tas
  fullname: van Beers-Tas, Marian H.
– sequence: 3
  givenname: Johanna M.
  surname: Kroese
  fullname: Kroese, Johanna M.
– sequence: 4
  givenname: Lotte A.
  surname: van de Stadt
  fullname: van de Stadt, Lotte A.
– sequence: 5
  givenname: Dirkjan
  surname: van Schaardenburg
  fullname: van Schaardenburg, Dirkjan
– sequence: 6
  givenname: Michael T.
  surname: Nurmohamed
  fullname: Nurmohamed, Michael T.
BookMark eNqNktuLEzEUxgdZcS_6HwgOCKIPrbln4oOwFC-FhQVvryFNMm1qOukmmaL_vakzys6yiORhwpnf-XK-w3denXShs1X1FII5xBy-3oY-dsrP96U8BwhzwNGD6gwKjGYMAXxy635anae0BYDihrFH1SlGnFBI4Vm1XKhoXDiopHuvYh1d-l67rt7bmEKXapWHUmhrYw_Wh73r1nXc2H6ncnCmVjFvossuPa4etson-2T8XlRf37_7svg4u7r-sFxcXs00YyLPmBYKrDDkqwYBTluNWIMQtITTlWGmJVgUI5hjoy1pgWACAypWXLdlegMtvqieDbp7H5Ict5AkIhgAAQTihVgOhAlqK_fR7VT8KYNy8nchxLUsUzvtrTRUUFRmUABpgixRTYMZbbC1xIimbYrW2_G1frWzZaYuR-UnotM_ndvIdThIjkVDiSgCL0eBGG56m7LcuaSt96qzoR_mLm4FxQV9fge9391IrVUx4Lo2lHf1UVReMgwJIqIhhZrfQ5Vj7M7pEpnWlfqk4dWkoTDZ_shr1ackl58__T97_W3KvrjFbqzyeZOC77Mr8ZqCZAB1DClF2_5dMgTymPg_25DHxMsx8aXtzZ027bI6qhfDzv-7-Rf9FQZ4
CitedBy_id crossref_primary_10_3390_ijms241310645
crossref_primary_10_3390_antib12040069
crossref_primary_10_1002_14651858_CD014741_pub2
crossref_primary_10_3389_fendo_2022_961505
crossref_primary_10_3389_fimmu_2023_1254753
crossref_primary_10_51847_EjiHWNs210
crossref_primary_10_1038_s41584_021_00593_3
crossref_primary_10_1136_rmdopen_2021_001591
crossref_primary_10_1002_14651858_CD014741
crossref_primary_10_4103_jfmpc_jfmpc_260_24
crossref_primary_10_3390_medicina58040558
crossref_primary_10_1016_j_jbspin_2023_105683
crossref_primary_10_4108_eetpht_9_39145
Cites_doi 10.1136/annrheumdis-2013-203682
10.1002/art.23650
10.1097/MD.0000000000005117
10.1016/j.semarthrit.2014.06.003
10.1177/0961203309351540
10.3899/jrheum.161184
10.1093/eurheartj/ehs380
10.1161/01.ATV.14.1.8
10.1016/S0895-7061(04)00897-0
10.1093/rheumatology/kew440
10.1503/cmaj.150535
10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#
10.1136/ard.2006.051672
10.1136/annrheumdis-2016-211066
10.1136/ard.2009.122374
10.1056/NEJMoa1012592
10.1136/ard.2008.105759
10.1016/j.semarthrit.2017.11.010
10.3899/jrheum.101143
10.1136/ard.2009.113696
10.2174/157016110791112269
10.1002/art.38944
10.1016/j.amjcard.2012.03.044
10.1016/j.cyto.2012.02.010
10.1186/s13075-015-0804-1
10.1007/s11882-014-0497-6
10.1097/01.hjr.0000277983.23934.c9
10.1002/art.10419
10.1136/annrheumdis-2012-201709
10.1093/rheumatology/keu224
10.3899/jrheum.170025
10.1016/j.autrev.2010.06.001
10.1007/s00281-017-0632-2
10.1038/nrrheum.2013.91
10.1002/art.20431
10.1136/bmj.j2099
10.1007/s13105-019-00694-4
10.1093/rheumatology/kes243
10.1016/j.ebiom.2016.02.029
10.1093/ehjcvp/pvz033
10.1136/annrheumdis-2012-201334
10.1002/art.20853
10.1136/bmj.k1036
10.1093/rheumatology/32.3.212
10.1136/ard.2008.101964
10.1016/j.atherosclerosis.2013.02.009
ContentType Journal Article
Copyright COPYRIGHT 2020 Public Library of Science
2020 van Boheemen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2020 van Boheemen et al 2020 van Boheemen et al
Copyright_xml – notice: COPYRIGHT 2020 Public Library of Science
– notice: 2020 van Boheemen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2020 van Boheemen et al 2020 van Boheemen et al
DBID AAYXX
CITATION
IOV
ISR
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
RC3
7X8
5PM
DOA
DOI 10.1371/journal.pone.0237072
DatabaseName CrossRef
Opposing Viewpoints
Gale In Context: Science
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Database‎ (1962 - current)
Agricultural & Environmental Science Collection
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Materials Science Collection
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database (Proquest)
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
Biological Sciences
Agricultural Science Database
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Engineering Database
Nursing & Allied Health Premium
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
Proquest Central Premium
ProQuest One Academic (New)
ProQuest - Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList



MEDLINE - Academic



Agricultural Science Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
Dentistry
DocumentTitleAlternate Cardiovascular risk in persons at risk of rheumatoid arthritis
EISSN 1932-6203
ExternalDocumentID 2430090927
oai_doaj_org_article_d5952fc2a02c42e4a8836583ee4d98f8
PMC7398549
A631424984
10_1371_journal_pone_0237072
GeographicLocations Netherlands
GeographicLocations_xml – name: Netherlands
GroupedDBID ---
123
29O
2WC
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IGS
IHR
IHW
INH
INR
IOV
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
P62
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PV9
PYCSY
RNS
RPM
RZL
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
BBORY
PMFND
3V.
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
RC3
7X8
ESTFP
PUEGO
5PM
-
02
AAPBV
ABPTK
ADACO
BBAFP
KM
ID FETCH-LOGICAL-c669t-6c9a0b317b82075fc268221e475bd6df439072373dce4f09693059b7cf053d1e3
IEDL.DBID M48
ISSN 1932-6203
IngestDate Fri Nov 26 17:12:53 EST 2021
Wed Aug 27 01:18:35 EDT 2025
Thu Aug 21 18:05:48 EDT 2025
Sun Sep 28 12:02:49 EDT 2025
Fri Jul 25 10:33:23 EDT 2025
Tue Jun 17 20:14:46 EDT 2025
Tue Jun 10 20:50:56 EDT 2025
Fri Jun 27 03:57:54 EDT 2025
Fri Jun 27 04:36:12 EDT 2025
Thu May 22 21:21:04 EDT 2025
Tue Jul 01 01:11:07 EDT 2025
Thu Apr 24 23:12:22 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
License This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c669t-6c9a0b317b82075fc268221e475bd6df439072373dce4f09693059b7cf053d1e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Competing Interests: The authors have declared that no competing interests exist.
ORCID 0000-0003-3168-548X
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.pone.0237072
PMID 32745151
PQID 2430090927
PQPubID 1436336
PageCount e0237072
ParticipantIDs plos_journals_2430090927
doaj_primary_oai_doaj_org_article_d5952fc2a02c42e4a8836583ee4d98f8
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7398549
proquest_miscellaneous_2430373953
proquest_journals_2430090927
gale_infotracmisc_A631424984
gale_infotracacademiconefile_A631424984
gale_incontextgauss_ISR_A631424984
gale_incontextgauss_IOV_A631424984
gale_healthsolutions_A631424984
crossref_primary_10_1371_journal_pone_0237072
crossref_citationtrail_10_1371_journal_pone_0237072
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-08-03
PublicationDateYYYYMMDD 2020-08-03
PublicationDate_xml – month: 08
  year: 2020
  text: 2020-08-03
  day: 03
PublicationDecade 2020
PublicationPlace San Francisco
PublicationPlace_xml – name: San Francisco
– name: San Francisco, CA USA
PublicationTitle PloS one
PublicationYear 2020
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References E Bartoloni (pone.0237072.ref006) 2010; 9
ID del Rincon (pone.0237072.ref041) 2001; 44
J Hippisley-Cox (pone.0237072.ref015) 2017; 357
HM Kremers (pone.0237072.ref005) 2008; 58
H Maradit-Kremers (pone.0237072.ref009) 2005; 52
GC Drosos (pone.0237072.ref045); 2020
CS Crowson (pone.0237072.ref043) 2012; 110
S Boo (pone.0237072.ref016) 2016; 95
SA Turk (pone.0237072.ref036) 2017; 44
J Primdahl (pone.0237072.ref017) 2013; 72
A Bag-Ozbek (pone.0237072.ref024) 2015; 15
I Graham (pone.0237072.ref033) 2007; 14
VP van Halm (pone.0237072.ref007) 2007; 66
M Holmqvist (pone.0237072.ref004) 2017; 76
C Giraud (pone.0237072.ref031) 2019; 75
TE Toms (pone.0237072.ref025) 2010; 8
D Zhang (pone.0237072.ref034) 2016; 188
MM Nielen (pone.0237072.ref012) 2004; 50
M Hashizume (pone.0237072.ref029) 2012; 58
WH Ettinger (pone.0237072.ref028) 1994; 14
FA Koopman (pone.0237072.ref032) 2016; 6
C Turesson (pone.0237072.ref022) 2015; 17
F Salaffi (pone.0237072.ref018) 2018; 148
VK Kawai (pone.0237072.ref044) 2015; 67
J Shen (pone.0237072.ref046) 2018; 45
AM El-Barbary (pone.0237072.ref002) 2011; 38
AM Adlan (pone.0237072.ref038) 2014; 44
E Alemao (pone.0237072.ref042) 2017; 56
K Lauper (pone.0237072.ref026) 2017; 39
JF Polak (pone.0237072.ref047) 2011; 365
KP Liao (pone.0237072.ref011) 2013; 52
J Robertson (pone.0237072.ref023) 2013; 9
AM Kerola (pone.0237072.ref001) 2012; 71
G Fent (pone.0237072.ref049) 2019
MJ Peters (pone.0237072.ref014) 2010; 69
BR England (pone.0237072.ref013) 2018; 361
SJ Piha (pone.0237072.ref035) 1993; 32
E Choy (pone.0237072.ref020) 2014; 53
G Cambridge (pone.0237072.ref010) 2013; 228
SA Provan (pone.0237072.ref039) 2018; 48
M Aydemir (pone.0237072.ref037) 2010; 19
WH Bos (pone.0237072.ref019) 2010; 69
LA van de Stadt (pone.0237072.ref008) 2012; 71
NJ Goodson (pone.0237072.ref003) 2002; 46
A Hozawa (pone.0237072.ref040) 2004; 17
I Hollan (pone.0237072.ref027); 6
L Engelen (pone.0237072.ref048) 2013; 34
E Myasoedova (pone.0237072.ref021) 2010; 69
E Choy (pone.0237072.ref030) 2009; 68
References_xml – volume: 2020
  start-page: 2047487320906650
  ident: pone.0237072.ref045
  article-title: Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus
  publication-title: Eur J Prev Cardiol
– volume: 72
  start-page: 1771
  issue: 11
  year: 2013
  ident: pone.0237072.ref017
  article-title: Results from systematic screening for cardiovascular risk in outpatients with rheumatoid arthritis in accordance with the EULAR recommendations
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2013-203682
– volume: 58
  start-page: 2268
  issue: 8
  year: 2008
  ident: pone.0237072.ref005
  article-title: High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study
  publication-title: Arthritis Rheum
  doi: 10.1002/art.23650
– volume: 95
  start-page: e5117
  issue: 40
  year: 2016
  ident: pone.0237072.ref016
  article-title: Perceived and actual risk of cardiovascular disease in patients with rheumatoid arthritis in Korea: A cross-sectional study
  publication-title: Medicine (Baltimore).
  doi: 10.1097/MD.0000000000005117
– volume: 44
  start-page: 283
  issue: 3
  year: 2014
  ident: pone.0237072.ref038
  article-title: Autonomic function and rheumatoid arthritis: a systematic review
  publication-title: Semin Arthritis Rheum
  doi: 10.1016/j.semarthrit.2014.06.003
– volume: 19
  start-page: 255
  issue: 3
  year: 2010
  ident: pone.0237072.ref037
  article-title: Cardiac autonomic profile in rheumatoid arthritis and systemic lupus erythematosus
  publication-title: Lupus
  doi: 10.1177/0961203309351540
– volume: 44
  start-page: 580
  issue: 5
  year: 2017
  ident: pone.0237072.ref036
  article-title: The Relationship Between Cardiac Conduction Times, Cardiovascular Risk Factors, and Inflammation in Patients with Early Arthritis
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.161184
– volume: 34
  start-page: 2368
  issue: 30
  year: 2013
  ident: pone.0237072.ref048
  article-title: Reference Values for Arterial Measurements C. Reference intervals for common carotid intima-media thickness measured with echotracking: relation with risk factors
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehs380
– volume: 14
  start-page: 8
  issue: 1
  year: 1994
  ident: pone.0237072.ref028
  article-title: Cytokines decrease apolipoprotein accumulation in medium from Hep G2 cells
  publication-title: Arterioscler Thromb
  doi: 10.1161/01.ATV.14.1.8
– volume: 17
  start-page: 1005
  issue: 11
  year: 2004
  ident: pone.0237072.ref040
  article-title: Prognostic value of home heart rate for cardiovascular mortality in the general population: the Ohasama study
  publication-title: Am J Hypertens
  doi: 10.1016/S0895-7061(04)00897-0
– volume: 56
  start-page: 777
  issue: 5
  year: 2017
  ident: pone.0237072.ref042
  article-title: Comparison of cardiovascular risk algorithms in patients with vs without rheumatoid arthritis and the role of C-reactive protein in predicting cardiovascular outcomes in rheumatoid arthritis
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kew440
– year: 2019
  ident: pone.0237072.ref049
  article-title: First cardiovascular MRI study in individuals at risk of rheumatoid arthritis detects abnormal aortic stiffness suggesting an anti-citrullinated peptide antibody-mediated role for accelerated atherosclerosis
  publication-title: Ann Rheum Dis
– volume: 188
  start-page: E53
  issue: 3
  year: 2016
  ident: pone.0237072.ref034
  article-title: Resting heart rate and all-cause and cardiovascular mortality in the general population: a meta-analysis
  publication-title: CMAJ
  doi: 10.1503/cmaj.150535
– volume: 44
  start-page: 2737
  issue: 12
  year: 2001
  ident: pone.0237072.ref041
  article-title: High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors
  publication-title: Arthritis Rheum
  doi: 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#
– volume: 66
  start-page: 184
  issue: 2
  year: 2007
  ident: pone.0237072.ref007
  article-title: Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2006.051672
– volume: 76
  start-page: 1642
  issue: 10
  year: 2017
  ident: pone.0237072.ref004
  article-title: Acute coronary syndrome in new-onset rheumatoid arthritis: a population-based nationwide cohort study of time trends in risks and excess risks
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2016-211066
– volume: 69
  start-page: 1310
  issue: 7
  year: 2010
  ident: pone.0237072.ref021
  article-title: Total cholesterol and LDL levels decrease before rheumatoid arthritis
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2009.122374
– volume: 365
  start-page: 213
  issue: 3
  year: 2011
  ident: pone.0237072.ref047
  article-title: Sr. Carotid-wall intima-media thickness and cardiovascular events
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1012592
– volume: 69
  start-page: 490
  issue: 3
  year: 2010
  ident: pone.0237072.ref019
  article-title: Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2008.105759
– volume: 148
  start-page: w14656
  year: 2018
  ident: pone.0237072.ref018
  article-title: The Expanded Risk Score in Rheumatoid Arthritis (ERS-RA): performance of a disease-specific calculator in comparison with the traditional prediction scores in the assessment of the 10-year risk of cardiovascular disease in patients with rheumatoid arthrit
  publication-title: Swiss Med Wkly
– volume: 48
  start-page: 134
  issue: 1
  year: 2018
  ident: pone.0237072.ref039
  article-title: Evidence of reduced parasympathetic autonomic regulation in inflammatory joint disease: A meta-analyses study
  publication-title: Semin Arthritis Rheum
  doi: 10.1016/j.semarthrit.2017.11.010
– volume: 38
  start-page: 828
  issue: 5
  year: 2011
  ident: pone.0237072.ref002
  article-title: Association of anti-modified citrullinated vimentin with subclinical atherosclerosis in early rheumatoid arthritis compared with anti-cyclic citrullinated peptide
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.101143
– volume: 69
  start-page: 325
  issue: 2
  year: 2010
  ident: pone.0237072.ref014
  article-title: EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2009.113696
– volume: 8
  start-page: 301
  issue: 3
  year: 2010
  ident: pone.0237072.ref025
  article-title: Dyslipidaemia in rheumatoid arthritis: the role of inflammation, drugs, lifestyle and genetic factors
  publication-title: Curr Vasc Pharmacol
  doi: 10.2174/157016110791112269
– volume: 67
  start-page: 381
  issue: 2
  year: 2015
  ident: pone.0237072.ref044
  article-title: The ability of the 2013 American College of Cardiology/American Heart Association cardiovascular risk score to identify rheumatoid arthritis patients with high coronary artery calcification scores
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.38944
– volume: 110
  start-page: 420
  issue: 3
  year: 2012
  ident: pone.0237072.ref043
  article-title: Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2012.03.044
– volume: 58
  start-page: 424
  issue: 3
  year: 2012
  ident: pone.0237072.ref029
  article-title: Atherogenic effects of TNF-alpha and IL-6 via up-regulation of scavenger receptors
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2012.02.010
– volume: 17
  start-page: 284
  year: 2015
  ident: pone.0237072.ref022
  article-title: High serum cholesterol predicts rheumatoid arthritis in women, but not in men: a prospective study
  publication-title: Arthritis Res Ther
  doi: 10.1186/s13075-015-0804-1
– volume: 15
  start-page: 497
  issue: 2
  year: 2015
  ident: pone.0237072.ref024
  article-title: Inflammation, adiposity, and atherogenic dyslipidemia in rheumatoid arthritis: is there a paradoxical relationship?
  publication-title: Curr Allergy Asthma Rep
  doi: 10.1007/s11882-014-0497-6
– volume: 14
  start-page: S1
  issue: Suppl 2
  year: 2007
  ident: pone.0237072.ref033
  article-title: European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).
  publication-title: Eur J Cardiovasc Prev Rehabil
  doi: 10.1097/01.hjr.0000277983.23934.c9
– volume: 46
  start-page: 2010
  issue: 8
  year: 2002
  ident: pone.0237072.ref003
  article-title: Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients
  publication-title: Arthritis Rheum
  doi: 10.1002/art.10419
– volume: 71
  start-page: 1915
  issue: 11
  year: 2012
  ident: pone.0237072.ref008
  article-title: Dyslipidaemia in patients with seropositive arthralgia predicts the development of arthritis
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2012-201709
– volume: 53
  start-page: 2143
  issue: 12
  year: 2014
  ident: pone.0237072.ref020
  article-title: Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment
  publication-title: Rheumatology (Oxford).
  doi: 10.1093/rheumatology/keu224
– volume: 45
  start-page: 218
  issue: 2
  year: 2018
  ident: pone.0237072.ref046
  article-title: Underestimation of Risk of Carotid Subclinical Atherosclerosis by Cardiovascular Risk Scores in Patients with Psoriatic Arthritis
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.170025
– volume: 9
  start-page: 701
  issue: 10
  year: 2010
  ident: pone.0237072.ref006
  article-title: How early is the atherosclerotic risk in rheumatoid arthritis?
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2010.06.001
– volume: 39
  start-page: 447
  issue: 4
  year: 2017
  ident: pone.0237072.ref026
  article-title: Cardiovascular risk in patients with rheumatoid arthritis
  publication-title: Semin Immunopathol
  doi: 10.1007/s00281-017-0632-2
– volume: 9
  start-page: 513
  issue: 9
  year: 2013
  ident: pone.0237072.ref023
  article-title: Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/nrrheum.2013.91
– volume: 50
  start-page: 2423
  issue: 8
  year: 2004
  ident: pone.0237072.ref012
  article-title: Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis
  publication-title: Arthritis Rheum
  doi: 10.1002/art.20431
– volume: 357
  start-page: j2099
  year: 2017
  ident: pone.0237072.ref015
  article-title: Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study
  publication-title: BMJ
  doi: 10.1136/bmj.j2099
– volume: 75
  start-page: 453
  issue: 4
  year: 2019
  ident: pone.0237072.ref031
  article-title: Alterations of HDL particle phospholipid composition and role of inflammation in rheumatoid arthritis
  publication-title: J Physiol Biochem
  doi: 10.1007/s13105-019-00694-4
– volume: 52
  start-page: 45
  issue: 1
  year: 2013
  ident: pone.0237072.ref011
  article-title: Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kes243
– volume: 6
  start-page: 231
  year: 2016
  ident: pone.0237072.ref032
  article-title: Autonomic Dysfunction Precedes Development of Rheumatoid Arthritis: A Prospective Cohort Study
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2016.02.029
– volume: 6
  start-page: 104
  issue: 2
  ident: pone.0237072.ref027
  article-title: Lipid management in rheumatoid arthritis: a position paper of the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology
  publication-title: Eur Heart J Cardiovasc Pharmacother
  doi: 10.1093/ehjcvp/pvz033
– volume: 71
  start-page: 1606
  issue: 10
  year: 2012
  ident: pone.0237072.ref001
  article-title: How early in the course of rheumatoid arthritis does the excess cardiovascular risk appear?
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2012-201334
– volume: 52
  start-page: 402
  issue: 2
  year: 2005
  ident: pone.0237072.ref009
  article-title: Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study
  publication-title: Arthritis Rheum
  doi: 10.1002/art.20853
– volume: 361
  start-page: k1036
  year: 2018
  ident: pone.0237072.ref013
  article-title: Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications
  publication-title: BMJ
  doi: 10.1136/bmj.k1036
– volume: 32
  start-page: 212
  issue: 3
  year: 1993
  ident: pone.0237072.ref035
  article-title: Elevated resting heart rate in rheumatoid arthritis: possible role of physical deconditioning
  publication-title: Br J Rheumatol
  doi: 10.1093/rheumatology/32.3.212
– volume: 68
  start-page: 460
  issue: 4
  year: 2009
  ident: pone.0237072.ref030
  article-title: Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.2008.101964
– volume: 228
  start-page: 243
  issue: 1
  year: 2013
  ident: pone.0237072.ref010
  article-title: Antibodies to citrullinated peptides and risk of coronary heart disease
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2013.02.009
SSID ssj0053866
Score 2.3982017
Snippet Background Rheumatoid arthritis (RA) is associated with an increased cardiovascular disease (CVD) risk which may start even before diagnosis. To explore this...
Rheumatoid arthritis (RA) is associated with an increased cardiovascular disease (CVD) risk which may start even before diagnosis. To explore this CVD risk...
BackgroundRheumatoid arthritis (RA) is associated with an increased cardiovascular disease (CVD) risk which may start even before diagnosis. To explore this...
Background Rheumatoid arthritis (RA) is associated with an increased cardiovascular disease (CVD) risk which may start even before diagnosis. To explore this...
SourceID plos
doaj
pubmedcentral
proquest
gale
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage e0237072
SubjectTerms Age
Angina pectoris
Antibodies
Antihypertensives
Apolipoproteins
Arthralgia
Arthritis
Autoantibodies
Autoimmune diseases
Biology and Life Sciences
Blood lipids
Blood pressure
Cardiovascular disease
Cardiovascular diseases
Cholesterol
Citrulline
Clinical medicine
Control methods
Coronary vessels
Demographics
Demography
Dentistry
Diagnosis
Ethnicity
Health aspects
Health risks
Heart diseases
Heart rate
High density lipoprotein
Immunology
Lipids
Lipoproteins (high density)
Medicine and Health Sciences
Physiological aspects
Rheumatoid arthritis
Rheumatoid factor
Rheumatology
Risk analysis
Risk factors
Triglycerides
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELXQnrggyocaKGAQEnBIm9iOHR9LRdUiARJQ1JsVO3Z3pSpZNbv_n_HHhlpCKgeu8TiKn2fi52TmGaG3opO1Mz0pjdC6ZKaSZds6WVLZM9I519pwDtmXr_zsgn2-bC5vHfXlc8KiPHAE7qhvZEOcIV1FDCOWdW1LYdWk1rJeti6U-Vay2m2m4jsYopjzVChHRX2U5uVwPQ72EFYpUQmSLURBr39-Ky_W1-OUUc48YfLWCnT6ED1I1BEfx0feQ_fs8AjtpeCc8PukIP3hMTo_ybJMsc8fx6sBrwO9nnC3iZdGh_8UTeGbpd0Cfx1XPQZYlkHt6Am6OP308-SsTGcmlIZzuSm5kV2lgRRoWNpFA8BxoAC1ZaLRPe8d8A8YOxUUxsIc7F8kBLzUwjgAra8tfYoWA6C0jzB11JqKE1k1GkhXDzsP7YA_2abuKKekQHQHoDJJUNyfa3Gtwl8yARuLCIzysKsEe4HKudc6CmrcYf_Rz81s6-WwwwVwEpWcRN3lJAV65WdWxdrSOajVMae-0k-2rEBvgoWXxBh8zs1Vt50mdf7t1z8Y_fieGb1LRm4EOEyX6hxgTF5qK7M8yCwhsE3WvO_9cIfKpAijwIgrSQT03Pnm35tfz83-pj6PbrDjNtpQ_2-WFkhkPp0BnLcMq2XQHYd-bcPks_8xI8_RfeK_XPjkG3qAFpubrX0B9G6jX4ZI_g2TcU3j
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELbK9gAX1BZQAwUCQgIOabO2Y8cHhNrSqkViQYWi3qLEj-5KVbJsdv9_ZxJniyUEXONxIs_Ln-N5EPJGlmrstKGJllWVcJ2qJM-dSpgynJbO5bbrQ_ZlIs4u-eer7GqDTIZcGAyrHHxi56hNo_Ef-QHlDOBAqqj8OP-VYNcovF0dWmiUvrWC-dCVGLtHNsElZ-mIbB6dTL5dDL4ZrFsIn0DH5PjAy2t_3tR2H3YvmUoabFBdHf-1tx7Nb5o2gKJhIOVvO9PpFnnoIWV82OvANtmw9Q65_wnDgLCT2w7Z9gbcxu98len3j8j5cRCJGmOMeTyr43kHwdu4XPaPGhffJVbFi6ldAcZtZiYGnZt2FZEek8vTkx_HZ4nvq5BoIdQyEVqVaQXAoYLtX2ZOUwEwYWy5zCojjAOMAnxgksG6uIMzjgKnoCqpHTDQjC17QkY1cGyXxMwxq1NBVZpVAMwMnE4qBxjLZuOSCUYjwgZmFtoXHcfeFzdFd5Mm4fDRM6lAERReBBFJ1rPmfdGNf9AfoZzWtFgyu3vQLK4Lb4GFyVRGYa1lSjWnlpd5zgB-MWu5UbnLI_ISpVz0-adrwy8OBcNsQJXziLzuKLBsRo1xOdflqm2L868__4Po-0VA9NYTuQbYoUufCwFrwnJcAeVeQAnGr4PhXdTJgSttcWcmMHPQ0z8Pv1oP40sx1q62zaqnYXh_yyIiA_0OGByO1LNpV5sc5uUZV0___vFn5AHF_xYYesP2yGi5WNnnAO6W1QtvsbfYpk_q
  priority: 102
  providerName: ProQuest
Title Cardiovascular risk in persons at risk of developing rheumatoid arthritis
URI https://www.proquest.com/docview/2430090927
https://www.proquest.com/docview/2430373953
https://pubmed.ncbi.nlm.nih.gov/PMC7398549
https://doaj.org/article/d5952fc2a02c42e4a8836583ee4d98f8
http://dx.doi.org/10.1371/journal.pone.0237072
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3Nb9MwFLdGd-GCGB9aYSsGIQGHVIntxPEBoa1a2ZAYaFDUW5Q49lqpSkrTSuO_59lxApaGxiWH-DmSf_Gzf_b7Qug1z0WkZUkCyYsiYDIUQZpqEVBRMpJrnSpbh-zzZXI-Y5_m8XwPdTVbHYDNrUc7U09qtlmNb37--gAK_95WbeBR12m8ris1hj2IhxwW5X1rMTLOfKy3K4B2W-ulYS1BQkLqgun-9RVvs7I5_fuVe7Be1Y1HS32nyr92qelD9MDRS3zSzocDtKeqR-jAKXCD37os0-8eo4uJ54mKjY85XlZ4bSl4g_Nt-6rW-E9gFd4s1A44br0sMcy5hc2I9ATNpmffJ-eBq6sQyCQR2yCRIg8LIA4FbP881pIkQBMixXhclEmpgaPA2CmnMBam4YwjYFEQBZcaACwjRZ-iQQUoHSJMNVUyTIgI4wKIWQmnk0IDx1JxlNOEkiGiHYCZdEnHTe2LVWYtaRwOHy0wmYE9c7APUdD3WrdJN-6QPzX_ppc1KbPti3pznTkNzMpYxATGmodEMqJYnqYU6BdVipUi1ekQvTB_NmvjT3vFz04SaqIBRcqG6JWVMGkzKuOXc53vmia7-PLjP4S-XXlCb5yQrgEOmbtYCBiTScflSR55kqD80ms-NPOwQ6XJCKPAmkNBOPTs5ubtzS_7ZvNR42tXqXrXylBjv6VDxL057QHst1TLhc1NDv3SmIlnd4L5HN0n5urCeN_QIzTYbnbqGPjdthihe3zO4ZlOIvOcfhyh_dOzy69XI3tjMrIq_RuKlFNy
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbK9lAuiBZQFwoNCAQc0mZtJ44PFepTu7RdUGmr3kLiR3elKlk2u0L8OX4bM4mzJRICLr3G40SZGc98tudByGuRyp5VmvpKZJnPVSD9OLbSZ1Jzmlobm6oP2ekw6l_wj1fh1RL52eTCYFhlYxMrQ60LhWfk25QzgAOBpOLD5JuPXaPwdrVpoZG61gp6pyox5hI7js2P77CFK3cGByDvN5QeHZ7v933XZcBXUSRnfqRkGmTgRjNwhiK0ikbgNHuGizDTkbbgsQNBmWBaGW4B8UtYIjITyoL-6p5h8N57ZJnjAUqHLO8dDj-fNb4ArEkUuYQ9JnrbTj-2JkVutsBbikDQlkOs-gYsvENnclOULejbDtz8zRMePSQPHIT1dmudWyVLJl8jKwcYdoSd49bIqjMYpffOVbV-_4gM9luRrx7GtHvj3JtUkL_00ln9qLDebSKXNx2ZOWDqYqw90PFRVYHpMbm4Ew4_IZ0cOLZOPGaZUUFEZRBmAAQ17IYyC5jOhL2URYx2CWuYmShX5Bx7bdwk1c2dgM1OzaQERZA4EXSJv5g1qYt8_IN-D-W0oMUS3dWDYnqduBWf6FCGFP41Daji1PA0jhnAPWYM1zK2cZdsopSTOt91YWiS3Yhh9qGMeZe8qiiwTEeOcUDX6bwsk8Gny_8g-nLWInrriGwB7FCpy72Af8LyXy3KjRYlGBvVGl5HnWy4Uia3yxJmNnr65-GXi2F8Kcb25aaY1zQM74tZl4iWfrcY3B7Jx6OqFjrMi0Mun_7945tkpX9-epKcDIbHz8h9imcmGPbDNkhnNp2b5wAsZ9kLt3o98vWuDcYv7QWLNQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJwEviA3QCoMZBAIesqW2E8cPE9rWVSuDMo0N7c0k_lgrTUlpWiH-Rf4qzonTEQkBL3uNz4lyd7772b4PhF7yVPSs0iRQPMsCpkIRJIkVARWakdTaxFR9yD6O4qNz9v4iulhBP5tcGBdW2djEylDrQrkz8h3CKMCBUMBW3fqwiJP-4N30W-A6SLmb1qadRurbLOjdqtyYT_I4Nj--w3au3B32QfavCBkcnh0cBb7jQKDiWMyDWIk0zMClZuAYeWQVicGB9gzjUaZjbcF7h5xQTrUyzAL6F7BcRMaVBV3WPUPhvbfQKgevDxvB1f3D0clp4xfAssSxT96jvLfjdWV7WuRmGzwnDzlpOceqh8DSU3SmV0XZgsHtIM7fvOLgPrrn4Szeq_VvDa2YfB3d6bsQJNdFbh2teeNR4je-wvXbB2h40IqCxS6-HU9yPK3gf4nTef2osPg6qQvPxmYB-LqYaAz6Pq6qMT1E5zfC4UeokwPHNhCmlhoVxkSEUQagUMPOKLOA70zUS2lMSRfRhplS-YLnru_Glaxu8ThsfGomSScC6UXQRcFy1rQu-PEP-n0npyWtK9ddPShml9KvfqkjERH41zQkihHD0iShAP2oMUyLxCZdtOWkLOvc16XRkXsxdZmIImFd9KKicCU7cqf8l-miLOXw05f_IPp82iJ67YlsAexQqc_DgH9ypcBalJstSjA8qjW84XSy4Uopr5cozGz09M_Dz5fD7qUuzi83xaKmoe7umHYRb-l3i8HtkXwyruqiw7wkYuLx3z--hW6D4ZAfhqPjJ-gucccnLgKIbqLOfLYwTwFjzrNnfvFi9PWm7cUvwbKPeQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cardiovascular+risk+in+persons+at+risk+of+developing+rheumatoid+arthritis&rft.jtitle=PloS+one&rft.au=van+Schaardenburg%2C+Dirkjan&rft.au=Nurmohamed%2C+Michael+T&rft.au=van+Boheemen%2C+Laurette&rft.au=Kroese%2C+Johanna+M&rft.date=2020-08-03&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=15&rft.issue=8&rft.spage=e0237072&rft_id=info:doi/10.1371%2Fjournal.pone.0237072&rft.externalDBID=n%2Fa&rft.externalDocID=A631424984
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon